Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript March 12, 2025
Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.5 EPS, expectations were $-0.01.
Operator: Good morning, ladies and gentlemen, and welcome to Anika’s Fourth Quarter and Year End Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] Also note that this call is...
